Baxter annouces $15m+ investment

Baxter Healthcare Ltd have announced a multi-million-dollar investment to develop a modern aseptic compounding facility in Sandyford, Dublin that will increase domestic production capacity.

The first phase of the project has already received its good manufacturing practices (GMP) licence from the Healthcare Products Regulatory Authority (HPRA). Construction for phase two is underway and expected to finish before the end of this year, pending HPRA audit and approval. Completion of the facility will build on Baxter’s more than 50-year history in Ireland and the company’s ongoing commitment to its people, patients and customers across the country.

Aseptic compounding is a complex process that involves the reconstitution or ‘mixing’ of drugs into patient-specific and batch, ready-to-use intravenous (IV) preparations for both hospital and home treatments.

This includes parenteral nutrition (nutrients fed through an IV), IV chemotherapy and home IV antibiotics (through the HSE National Community Intervention Team, Outpatient Parenteral Antimicrobial Therapy (OPAT) Programme). Aseptic reconstitution by commercial providers provides a critical service to the Irish healthcare system.

This service accounts for a significant proportion of the reconstituted product used by hospitals daily and plays a critical role in expanding homecare.

Source link

Latest

Three pedestrians killed in 24 hours as police urge caution on long weekend

Police said a 32-year-old man was treated at the...

Firefly Aerospace’s Alpha rocket reaches orbit for 1st time

A new rocket just earned its wings.Firefly Aerospace's Alpha...

Apple Watch Ultra review: this rugged fitness watch is Apple’s best for years

The Apple Watch Ultra is the most exciting thing...

Playbook Deep Dive – POLITICO

Welcome to Playbook Deep Dive, the stories behind the...